Vela Diagnostics - Vela Diagnostics has announced that the ViroKey™ Flu A/B & RSV RT-PCR Extension Kit has received the CE mark for in vitro diagnostics use. “The flu season and the
Vela Diagnostics | LinkedIn
Vela Gets Emergency Use Authorization for Zika Test | Clinical Lab Products
Vela Diagnostics – Sample to Results qPCR and NGS Solutions - Vela Diagnostics
Vela Diagnostics - News, Articles, Whitepapers - Drug Target Review
Vela Diagnostics Company Profile: Acquisition & Investors | PitchBook
Vela Diagnostics Expands into Microbiology with Great Basin Scientific Acquisition
Gerd Michel and Lou Welebob - Mutation Detection Simplified - From Liquid Biopsy in clinical oncolog - YouTube
Vela Diagnostics expands automation options for COVID RT-PCR test | ROI-NJ
Vela Diagnostics Pte. Ltd. - Crunchbase Company Profile & Funding
Prospective Evaluation of the Vela Diagnostics Next-Generation Sequencing Platform for HIV-1 Genotypic Resistance Testing - ScienceDirect
BARDA contracts Vela Diagnostics to develop Covid-19 tests
Complete “Sample-to-Result” Highly Automated NGS and qPCR Workflow for Clinical Diagnostics Poster | Technology Networks
Vela Diagnostics announces new automation options for ViroKey test
Vela Diagnostics - Vela Diagnostics has started shipping the ViroKey™ SARS-CoV-2 RT-PCR Test to laboratories and distributors across the #US, #Europe, #Thailand, #Vietnam, #Indonesia and #Dubai. Vela Diagnostics stands in solidarity with
La prueba ViroKey SARS-CoV-2 RT-PCR de Vela Diagnostics obtuvo la autorización de uso en emergencias de la FDA - COVID-19 - Hospimedica.es
Vela Diagnostics | LinkedIn
IJMS | Free Full-Text | Analytical Assessment of the Vela Diagnostics NGS Assay for HIV Genotyping and Resistance Testing: The Apulian Experience